A general pattern: Cardiovascular outcomes: semaglutide has stronger evidence Weight loss and glucose control: orforglipron is competitive and sometimes leads Convenience: orforglipron is simpler to use Medicare coverage If you have Medicare, you can get a pharmacy benefit card to buy Foundayo for $50 a month
Killion EA et al (2020) Glucose-Dependent Insulinotropic Polypeptide Receptor Therapies for the Treatment of Obesity, Do Agonists = Antagonists
& Datta, M
For personalized skincare solutions, consult with professionals at DermaPrecision, where we tailor treatments to meet your unique needs.
Rouille, Y., Westermark, G., Martin, S
Retatrutide belongs to the next wave of research, but interest should be separated from approval